Firm
As Marshall Gerstein celebrates its 70-year anniversary, Jeffrey Sharp, managing partner, reflects on lessons that shaped both his career and the firm’s success
News of two pharma deals involving Novo Nordisk and GSK and a loss for Open AI were also among the top talking points
Howard Hogan, IP partner at Gibson Dunn, says AI deepfakes are driving lawyers to rethink how IP protects creativity and innovation
Evarist Kameja and Hadija Juma at Bowmans explain why a new law in Tanzania marks a significant shift in IP enforcement
Sponsored
Sponsored
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos analyses a ruling confirming that patent claims must be interpreted with reference to the description and drawings -
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Anita Rawat of RNA, Technology and IP Attorneys address the main questions concerning India’s regulation of greenwashing across advertising, financial products, and the food sector
-
Sponsored by Wanhuida Intellectual PropertyAs an AstraZeneca patent survives a tenth invalidation challenge in China, Jianhui Li of Wanhuida Intellectual Property considers the implications for generic drug makers and the pharmaceutical industry
-
Sponsored by Tilleke & GibbinsSuebsiri Taweepon of Tilleke & Gibbins highlights a critical issue in Thailand’s copyright regime while examining the legal uncertainties, licensing burdens, and data-scraping risks in AI development
-
Sponsored by Patrinos & KilimirisMaria Kilimiris of Patrinos & Kilimiris says the decision on the ‘Belvedere Mykonos Club’ mark highlights the importance of complementary goods and services as a factor in opposition cases
-
Sponsored by Cabinet M OproiuIn this opening article of a series, Raluca Vasilescu of Cabinet M Oproiu explains her conclusions after experimenting with various AI assistants when responding to office actions in patent applications
